DOI: 10.1055/s-00030576

Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics

Referenz

Haab F, Stewart L, Dwyer P.
Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder.

Eur Urol 2004;
45 (4) 420-429 , discussion 429

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in:
Aufrufen in: